Indeed, many studies confirmed that PTER exerts antiproliferative and proapoptotic effects in both solid (e.g., lung, gastric, prostate, colon, and breast cancers) [15], [17]–[20] and non-solid tumors (e.g., chronic myelogenous leukemia and lymphoblastic leukemia) [21], [22]. Here, PTER is linked to breast carcinoma.